Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can virtual reality ease breathlessness? brain scans seek answers

NCT ID NCT07319039

First seen Jan 09, 2026 · Last updated Jun 23, 2026 · Updated 25 times

Summary

This study uses brain scans (fMRI) to see how breathlessness affects the brain in people with advanced cancer, COPD, or heart failure. Researchers will also test if immersive virtual reality can help reduce breathlessness. The goal is to see if this approach is feasible for a larger study, not to prove a treatment works yet.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Geneva University Hospitals

    RECRUITING

    Geneva, Canton of Geneva, 1211, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could reveal how different diseases cause breathlessness and whether virtual reality can help ease it.

What could go wrong

This is a very small, early feasibility study with only 16 participants, so results may not apply broadly. It focuses on measuring feasibility, not proving treatment effectiveness.

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease Dyspnea heart failure neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.